Publication | Closed Access

Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells

AngiogenesisEndothelial CellsReceptor Tyrosine KinaseImmunologyEndothelial DysfunctionVascular BiologyVegf-induced Tyrosine PhosphorylationNeovascularizationVascular Endothelial Growth FactorMedicineCell BiologyCell SignalingAntiangiogenic Effect